Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.33 |
| ▸ | METAP1 | P53582 | 1/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.30 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.30 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.30 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18372916 | 0.90 | LPAR5 (0.37) | SMPD1LPAR5LPAR1LPAR3TDP1 | |
| SCHEMBL21291945 | 0.87 | METAP1 (0.32) | SMPD1METAP1TDP1PPARDTSHR | |
| SCHEMBL29143313 | 0.83 | TDP1 (0.50) | SMPD1LPAR5METAP1LPAR1LPAR3 | |
| SCHEMBL4624439 | 0.81 | HSD17B10 (0.40) | SMPD1LPAR5TDP1PTPN1 | |
| SCHEMBL21291931 | 0.80 | LPAR5 (0.50) | SMPD1LPAR5LPAR1LPAR3TDP1 | |
| SCHEMBL18372917 | 0.79 | LPAR5 (0.34) | SMPD1LPAR5LPAR1LPAR3TDP1 | |
| SCHEMBL26188134 | 0.79 | TSHR (0.35) | SMPD1LPAR5LPAR1LPAR3TDP1 | |
| SCHEMBL7176541 | 0.79 | LPAR5 (0.57) | SMPD1LPAR5LPAR1LPAR3LPAR6 | |
| SCHEMBL19449080 | 0.78 | SMPD1 (0.32) | SMPD1TDP1 | |
| SCHEMBL21291920 | 0.77 | LPAR5 (0.59) | SMPD1LPAR5LPAR1LPAR3LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | claimed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | claimed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | claimed |
| CN-110183603-B | Phosphorus-containing release agent, optical polymerizable composition containing same, and method for producing same | SKC株式会社 | 2023-04-07 | — | — | CN | disclosed |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | SKC CO., LTD. (KR) | 2022-02-15 | — | — | US | disclosed |
| CN-110183603-A | Phosphorous release agent, including its optics polymerizable composition, polymerizable composition and preparation method thereof | SKC株式会社 | 2019-08-30 | — | — | CN | disclosed |
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SK PUCORE CO., LTD. (KR) | 2019-08-29 | — | — | US | disclosed |
| EP-3530684-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | SKC Co., Ltd. (KR) | 2019-08-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263846-A1 | PHOSPHORUS-BASED RELEASING AGENT, OPTICAL POLYMERIZABLE COMPOSITION COMPRISING SAME AND PREPARATION THEREOF | PMM2, PGM2, IPMK | SMPD1 3130/4885LPAR5 2371/4885METAP1 2888/4885 |
| US-11248011-B2 | Phosphorus-based releasing agent, optical polymerizable composition comprising same and preparation thereof | PMM2, PGM2, IPMK | SMPD1 3130/4885LPAR5 2371/4885METAP1 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.